comparemela.com

Latest Breaking News On - Founded entity - Page 6 : comparemela.com

PureTech s Karuna receives positive results from its KarXT blood pressure trial

PureTech's Karuna receives positive results from its KarXT blood pressure trial

Steve brannanKaruna therapeutics incPuretech healthDrug administration for karFounded entityKaruna therapeuticsNew drug applicationDrug administrationPressor effectsTech healthFounded entities

PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation

VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis Vedanta’s pipeline also includes VE303, its Phase 3 ready therapeutic.

United kingdomUnited statesJeffrey silberDrug administrationPuretech healthFounded entityVedanta biosciencesFast trackBiosciences announces first patient dosedUlcerative colitisReceives fast trackChief medical officerFounded entitiesPrivate securities litigation reform actTrack designationAnnual report

KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia

Founded Entity Karuna Therapeutics submits New Drug Application to U.S. Food and Drug Administration for KarXT for the treatment of schizophrenia If approved, KarXT will be the first new mechanism.

Eric elenkoDrug administration for karDrug administrationKaruna therapeutics incPuretech healthFounded entityKaruna therapeuticsNew drug applicationChief innovation officerNegative syndrome scaleTherapeutics submits new drug applicationBill meuryFounded entitiesRoyalty pharmaPrivate securities litigation reform actAnnual report

PureTech Health pinches Arix boss as new chief portfolio officer

Biotherapeutics company PureTech Health, which develops medicines to treat serious diseases, has appointed the boss of Arix Bioscience as its new chief portfolio officer.

United kingdomDaphne zoharArix bioscienceRobert lyneWholly owned programsFounded entityCategory allCategory company newsCategory news and announcements

PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer

PureTech Health plc , a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced the appointment of Robert Lyne as Chief.

City ofUnited kingdomUnited statesDaphne zoharRobert lyneArix bioscienceOxford brookes universityUniversity of oxfordPuretech healthChief portfolioTech announcesChief portfolio officerBusiness wireChief executive officerWholly owned programsFounded entity

vimarsana © 2020. All Rights Reserved.